Bulk fund order for ponatinib(iclusig) 15MG tablet for the seattle VAMC
Ended Awarded Last action
- Contract number
- 36C26019N0252
- Awardee
-
Ariad Pharmaceuticals, Inc. UEI EVMMLCKBZS47 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 20
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $172,533
Award facts
- Contract value 100% obligated
- $172,533.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Seattle, WA 98108, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$149,529 | |
| Funding Only Action | $184,035 | |
| Original award | $138,026 |
About this award
This contract is a delivery order issued by the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 20 for the purchase of Ponatinib (Iclusig) 15mg tablets for the Seattle VA Medical Center. The contract was awarded to Ariad Pharmaceuticals, Inc., a pharmaceutical company owned by Takeda Pharmaceutical Company Limited. The contract is a Blanket Purchase Agreement (BPA) call under the General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule (FSS-61-IB) and has a firm fixed price of $172,533.00. The contract does not have a set-aside designation and was awarded on January 1, 2019, with a completion date of December 31, 2019. This contract supports the VA's efforts to provide critical oncology medications to veterans in need.
Quick answers
Who was awarded contract 36C26019N0252?
36C26019N0252 was awarded to Ariad Pharmaceuticals, Inc. by Veterans Integrated Service Network 20 (Veterans Health Administration) on January 1, 2019.
How much is contract 36C26019N0252 worth?
The government has obligated $172,533 on 36C26019N0252.
Is contract 36C26019N0252 an order under another contract?
Yes. 36C26019N0252 is a BPA call under V797D50395-VA797P15A0016, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C26019N0252 competed?
The extent of competition for 36C26019N0252 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award